Literature DB >> 11845298

Electrodiffusional ATP movement through CFTR and other ABC transporters.

H F Cantiello1.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the superfamily of ATP-binding cassette (ABC) transporters, also known as traffic ATPases. Recent studies from our laboratory determined that various members of the ABC family of transport proteins mediate the electrodiffusional movement of the nucleotide ATP. In this report, evidence for the movement of cellular nucleotides by the ABC transporter CFTR and related molecules, including P-glycoproteins (Pgp), is reviewed. The wild-type mdr1 gene product, Pgp, enables the spontaneous release of cellular ATP. However, single amino acid substitutions in both nucleotide-binding sites render a dysfunctional Pgp, whose function can only be reversed by voltage activation. This report includes data indicating that reconstitution of highly purified CFTR from human epithelial origin enables the permeation of both Cl and ATP. The relevance of the ABC domains in ATP transport is also explored, and the hypothesis is forwarded that improper ATP transport by a dysfunctional CFTR is a relevant factor in cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11845298     DOI: 10.1007/s004240100639

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  16 in total

1.  CFTR channels and adenosine triphosphate release: the impossible rendez-vous revisited in skeletal muscle.

Authors:  Frédéric Becq
Journal:  J Physiol       Date:  2010-12-01       Impact factor: 5.182

2.  Purinergic receptors and regulatory volume decrease in seabream (Sparus aurata) hepatocytes: a videometric study.

Authors:  Agata Torre; Francesca Trischitta; Caterina Faggio
Journal:  Fish Physiol Biochem       Date:  2012-05-15       Impact factor: 2.794

3.  Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.

Authors:  Marianne Skals; Randi G Bjaelde; Jesper Reinholdt; Knud Poulsen; Brian S Vad; Daniel E Otzen; Jens Leipziger; Helle A Praetorius
Journal:  J Biol Chem       Date:  2014-05-23       Impact factor: 5.157

Review 4.  Establishment of cell-cell cross talk in the epididymis: control of luminal acidification.

Authors:  Winnie W C Shum; Ye Chun Ruan; Nicolas Da Silva; Sylvie Breton
Journal:  J Androl       Date:  2011-03-25

5.  Cyclic ADP-ribose requires CD38 to regulate the release of ATP in visceral smooth muscle.

Authors:  Leonie Durnin; Violeta N Mutafova-Yambolieva
Journal:  FEBS J       Date:  2011-08-08       Impact factor: 5.542

Review 6.  Purinergic regulation of duodenal surface pH and ATP concentration: implications for mucosal defence, lipid uptake and cystic fibrosis.

Authors:  J D Kaunitz; Y Akiba
Journal:  Acta Physiol (Oxf)       Date:  2011-01       Impact factor: 6.311

7.  Transport and cytotoxicity of paclitaxel, docetaxel, and novel taxanes in human breast cancer cells.

Authors:  Marie Ehrlichova; Radka Vaclavikova; Iwao Ojima; Antonella Pepe; Larisa V Kuznetsova; Jin Chen; Jaroslav Truksa; Jan Kovar; Ivan Gut
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-30       Impact factor: 3.000

8.  Wide nanoscopic pore of maxi-anion channel suits its function as an ATP-conductive pathway.

Authors:  Ravshan Z Sabirov; Yasunobu Okada
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

9.  HCO(3)(-)-dependent soluble adenylyl cyclase activates cystic fibrosis transmembrane conductance regulator in corneal endothelium.

Authors:  Xing Cai Sun; Chang-Bin Zhai; Miao Cui; Yanqiu Chen; Lonny R Levin; Jochen Buck; Joseph A Bonanno
Journal:  Am J Physiol Cell Physiol       Date:  2003-01-08       Impact factor: 4.249

10.  Role of purinergic signaling pathways in V-ATPase recruitment to apical membrane of acidifying epididymal clear cells.

Authors:  Clémence Belleannée; Nicolas Da Silva; Winnie W C Shum; Dennis Brown; Sylvie Breton
Journal:  Am J Physiol Cell Physiol       Date:  2010-01-13       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.